Debar Firm That Runs CCTVs At JK Lon Hosp: Health Dept Panel

Jaipur: The health department’s committee investigating the plasma theft at JK Lon Hospital revealed that 2,300 units of plasma are missing. The committee recommended debarring and blacklisting the firm responsible for installing and ensuring the functioning of CCTV cameras.

The committee suspects that the missing plasma units were stolen by lab technician, identified as Krishna Kant Kataria, who was apprehended for allegedly stealing plasma from the blood bank at JK Lon Hospital.

The committee checked the records of the past five years of the blood bank and found that 2,300 units of plasma were missing. The committee conducted an audit of the blood bank.

In the report, it was mentioned that the cost of 2,300 units of plasma is around Rs 14 lakh. It has recommended in the report that the cost of the plasma should be recovered from the accused.

The committee found excess units of plasma in a blood bank of a private hospital. Now, the health department has served a notice to the private hospital to explain where it got the excess plasma units.

The committee raised serious concerns about the security and integrity of the blood bank at JK Lon Hospital in its report. CCTVs were not found to be functioning.

Following the theft incident, the hospital administration has taken steps to curb such incidents. “We have formed a committee to ensure proper functioning of the blood bank. Besides, we have issued directions to keep all the CCTVs functioning in the hospital. Security has also been tightened in the blood bank,” Dr Kailash Meena, medical superintendent of JK Lon Hospital, told TOI.

To prevent such incidents, the health department will constitute a blood transfusion services unit that will be established under the director of public health to ensure the smooth operation of blood banks in the state.

Related Posts

  • Pharma
  • July 26, 2024
  • 127 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 125 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD